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Abstract - The purpose of this study was to validate a 
single BIA for predicting the risk in DHF in dengue 
patients in the Hospital Universiti Kebangsaan 
Malaysia (HUKM).  The BIA technique based on the 
passing of low-amplitude electrical current less than 1 
mA (500 to 800!A) with frequency 50kHz.  During 
hospitalization, 210 patients who are 119 males and 
91 females serologically confirmed DF and DHF 
patients were tested using single BIA.  By using 
multiple regression analysis, race, reactance, 
complication, headache and the day of fever were 
found independent determinants of predicting the 
risk.  Hence, this novel approach of BIA technique 
can provide rapid, non-invasive, and promising 
method for classifying and evaluating the status of 
the DHF patients.
Keywords: modeling, bioelectrical impedance, dengue 
fever, dengue hemorrhagic, risk, multivariate 
analysis.
I. INTRODUCTION 
 
Dengue infections are due to several types of 
dengue viruses.  Initially, it was difficult to 
differentiate dengue fever since its characteristics 
is similar to some other diseases.  An early study 
reported that between the years 1780 to 1940, a 
unique characteristic associated with dengue-like 
illness was the relatively infrequent but often large 
epidemics [1].  New dengue virus strains and 
serotypes were identified (DEN-1 in 1977, a new 
strain of DEN-2 in 1981, DEN-4 in 1981, a new 
strain of DEN-3 in 1994) [1].  They belong to the 
genus Flavivirus, family Flaviviridae, which 
contains approximately 70 viruses [1].  All 
flaviviruses have common group epitopes on the 
envelope protein that result in extensive cross-
reactions in serological test.  These make 
unequivocal serological diagnosis of flaviviruses 
difficult.  Infection with one dengue serotype 
provides lifelong immunity to that virus, but there 
is no cross-protective immunity to other serotypes.  
Thus, persons living in an area of endemic dengue 
can be infected with three, and probably four, 
dengue serotypes during their lifetime [1].   
 
Typical case of DHF is characterized by acute 
fever associated with reflecting a mild degree of 
plasma leakage; when the plasma loss is critical, it 
develops shock, which can lead to mortality.  
Several additional unique symptoms belong to 
DHF such as petechiae, ecchymoses, bleeding from 
the mucosa, injection sites and haematemesis can 
only be discriminated by medical experts.  The 
cases of DHF have been graded, according to the 
WHO specification, into four grades[2].  Grade I is 
defined as having a fever accompanied by non-
specific constitutional symptoms, the only 
haemorrhagic manifestation is a positive touniquet 
test that results in petechial rash.  Grade II is 
defined as patients having a spontaneous bleeding 
from any site of their body, i.e. skin.  Grade III is 
patients with circulatory failure manifested by 
rapid and weak pulse, narrowing of pulse pressure 
(20mmHg or less) or hypotension, with the 
presence of cold clammy skin and restlessness.  
Grade IV is defined as patients having profound 
shock with undetectable blood and pulse.   
 
DHF with plasma leakage may lead to dengue 
shock syndrome (DSS).  The condition of patients 
who progress to shock suddenly deteriorates after a 
fever of 2-7 days duration.  This deterioration 
occurs at the time of, or shortly after, the fall in 
temperature-between the third and the seventh day 
of the disease.  There are the typical signs of 
circulatory failure: the skin becomes cool, blotchy 
and congested; circumoral cyanosis is frequently 
observed; the pulse becomes rapid.  Patients may 
initially be lethargic, then become restless and 
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rapidly enter a critical stage of shock.  Acute 
abdominal pain is a frequent complaint shortly 
before the onset of shock. 
 
II. EPIDEMIOLOGY 
The first major outbreak of DHF in Malaysia 
occurred in 1973.  DEN-3 was considered to be the 
main causal type [3].  In 1998, the country 
experienced a large epidemic with 15493 notified 
cases, where 799 were cases of DHF with 99 
deaths [4].  It was thought that the El Nino weather 
phenomenon may have influenced the dengue 
infection [5].  It was warned that global warming 
has affected the pattern of dengue fever in several 
ways.  Figure 1  shows the trend of dengue 
situation in Malaysia from the year 1988 to 2001 
[4] [6].  The incidence rate of clinically diagnosed 
DF and DHF reported shows an upward trend from 
8.5 cases/100,000 populations in 1988 to 123.4 
cases/100,000 population in 1998.  Out of the 
16,368 cases reported in the year 2001, 22% were 
among children 14 years and below.  Similarly the 
case fatality rate (CFR) for DF is high, ranging 
from 5% to 6% per annum for both children and 
adults.  As expected, there have been more cases of 
DF than DHF, with a ratio of 16 – 25:1 over the 
last 5 years.  In the year 2001, the DF:DHF ratio in 
children was 6.7:1 as compared to 27.3:1 in adults. 
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Fig. 1 Number of cases, deaths and incidence rates (per 
100,000) in Malaysia, 1988-2003[6].  
 
 
III. BIOELECTRICAL IMPEDANCE 
ANALYSIS 
 
The BIA measurements were conducted by way of 
a tetrapolar configuration [7] using the BIA 450 
analyzer (Figure 2). The four electrode technique 
used by this system largely avoided the 
aforementioned difficulties faced when using the 
two electrode technique. Four surface electrodes 
were used: two electrodes were placed on the 
subject’s right hand, one at the base of knuckles 
and another slightly above the wrist joint. Another 
two electrodes were placed on the right foot, one 
near the base of the toes and the other slightly 
above the ankle joint.  
 
 
 
 
 
 
 
 
 
 
 
Fig. 2  Principle of bioelectrical impedance measurement using 
the four electrode technique. A and B are the current source 
electrodes (less than 1mA) while C and D are detecting 
electrodes. 
 
 
The BIA 450 analyzer delivered constant current 
less than 1mA at 50 kHz into the tissue via the 
electrodes attached at base of the knuckles and 
base of the toes (current electrodes between points 
A and B) and the signal was picked up by the other 
two sensor electrodes (voltage electrodes between 
points C and D) slightly above the ankle and wrist 
joints as shown in Figure 3. 
 
                 
                                       
                         
      
                               
Fig. 3 Electrodes placement on the right side of the wrist and 
ankle. Electrodes A and B are current sources while electrodes 
C and D are voltage pick-up [8]. 
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IV. PATIENTS AND METHODS 
 
Two hundred ten adult patients aged 12 years old 
and above, suspected of DF and DHF admitted to 
the Universiti Kebangsaan Malaysia Hospital 
(HUKM), were monitored.  For the first group, the 
severity of the DHF is classified into grade I to IV, 
according to WHO recommendation [2].  Acute 
dengue infection was confirmed subsequently by 
the use of ELISA to detect elevated dengue 
specific IgM (primary infection) and IgG 
(secondary infection) [9].  Patient serum samples 
were tested for hemoglobin determination using an 
automated counter (Coulter STKS machine).  The 
second group is the control group for healthy 
female and male subjects. 
 
All patients were required to follow the following 
guidelines to ensure accurate body composition 
results, no drinking and eating intake for 4 hours 
prior to the test, no alcohol consumption for 24 
hours prior to the test, no physical exercise for 12 
hours prior to the test.  The subjects were required 
to expose their right ankle and wrist during the BIA 
measurement.  Two electrodes were placed on the 
patient’s right hand, one the base of the knuckles 
and another slightly above the wrist joint.  Another 
two electrodes were placed on the right foot, one 
near the toes and the other slightly above the ankle 
joint. A constant current less than 1 mA and single 
frequency of 50 kHz was produced by a 
biodynamic Model 450 bioimpedance analyzer and 
injected to the base of the knuckles and base of the 
toes and the signal was picked up by the other two 
sensor electrodes.  Resistance, reactance, body 
capacitance and phase angle were measured by the 
BIA analyzer.  The clinical data were recorded 
using the standardized questionnaire data 
collection. 
 
The second groups of patients (control subjects) 
who do not have past medical history of dengue 
were recruited and studied using the same 
guidelines as in the BIA subject preparation used 
for the first group. The BIA safety measurements 
procedure and other safety precautions were made 
known to the subjects and their informed consent 
was obtained from each subject prior to the BIA 
measurement. 
 
 For the control subject, the weight was taken once.  
However for subjects with dengue infection, the 
weight was measured daily until upon discharged.  
 
V. STATISTICAL ANALYSIS 
 
Statistics were calculated with SPSS version 11.5, 
using non-parametric test because variables were 
not always normally distributed.  Correlations 
between variables were analyzed using Spearman’s 
rank correlation coefficient (") and multiple linear 
regression analysis was used to determine the 
independent effect of parameters related with 
hemoglobin.  Statistical significance was defined as 
P < 0.05 for all tests. 
 
VI. RESULTS 
Subjects were 210 patients, 119 males and 91 
females with mean age of 30.65 years.  
Correlations between variables were analyzed 
using Spearman’s correlation coefficient.  It is a 
standardized measure of the strength of the 
relationship between two variables that does not 
rely on the assumptions of a parametric test.   
 
Linear regression was used to identify the most 
significant variable among the bioelectrical 
impedance analysis parameters.  A significant 
variable were reactance, race, complication, 
headache and the day of fever (p<0.05). 
 
Table 1 shows the model parameters.  This model 
includes 19 variables predicting the risk, but only 
five variables are highly significant. 
 
 
TABLE 1 
SIGNIFICANT PARAMETERS FOR 210 PATIENTS ON 
DAY-OF-ADMISSIONS. 
 
Unstandardized Coefficients Standardized Coefficients 
B
(Constant) 0.928 3.855 0.000
RACE 0.099 2.777 0.006
COMPLICATION -0.037 -2.268 0.025
NO OF DAY 0.045 2.634 0.009
REACTANCE -0.013 -3.954 0.000
HEADACHE 0.200 2.219 0.028
DIZZFAIN -0.182 -1.740 0.084
WLIMB 0.124 1.195 0.234
ARTHALGIA 0.074 0.617 0.538
MYALGIA 0.002 0.014 0.989
BACKACHE 0.045 0.452 0.652
NAUSEA -0.077 -0.775 0.439
VOMITT -0.002 -0.020 0.984
ANOREXIA -0.003 -0.047 0.962
GASTRIC 0.051 0.663 0.508
P.RASH -0.022 -0.308 0.758
FLUSHF -0.036 -0.444 0.658
CHILLNR -0.043 -0.184 0.854
HEPA 0.070 0.723 0.470
BT 0.155 1.969 0.051
a. Dependent Variable:RISK
0.051
0.142
Model
-0.143
0.089
0.051
0.001
0.037
-0.065
0.082
0.233
0.097
0.079
0.193
-0.153
0.179
-0.276
0.163
0.099
0.099
0.177
0.072
0.077
0.072
0.003
0.090
0.105
0.103
0.120
0.120
Coefficients 
a
Std. Error Beta t Sig.
0.240
0.036
0.016
0.017
0.050
-0.021
-0.030
-0.012
-0.002
-0.003
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TABLE 2 
SYSTEM EFFICIENCY 
 
Model R R Square Adjusted Std. Error 
R Square of the Estimate
1 0.539 0.291 0.212 0.441  
 
 
Finally linear regression was used to identify all 
significant variables and adjusted R
2
Risk = 0.926 + 0.099 (race) - 0.037 (complication) 
+ 0.045 (the day of fever) – 0.013 (reactance) + 
0.20 (headache). 
 to 29% (Table 
2).  Hence the final model can be written as 
follows: 
 
 
VII. CONCLUSION 
In this developed model, five predictors such as 
race, reactance, complication, headache and the 
day of fever were the best predictive factors for 
modeling the risk in dengue patients.  New non-
invasive system to predicting the risk in DF and 
DHF was developed. 
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